News Releases

EndoChoice® Launches RescueNet™ Retrieval Device
New Retrieval Net to be Presented at DDW® 2016 and the SGNA 43rd Annual Course

ALPHARETTA, Ga., May 19, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced the full market release of its RescueNet retrieval device. Based upon the OmniLoop technology unveiled with the Boa® polypectomy snare, RescueNet's design also incorporates new ProMesh technology. RescueNet™ provides greater visibility and control with improved mesh strength, which allows for reliable and efficient foreign body removal.  The company is beginning sales and distribution in the United States, European Union, and other select markets.

EndoChoice® - RescueNet™ Retrieval Device

Since its recent introduction, RescueNet™ has been extremely well received by nurses and physicians. "The RescueNet is the best on the market today. It opens and closes in any position, adjustable, and works time after time. It never seems to wear out," stated Jerry Rayfield, GI Nurse Manager at Russell Medical Center, Alexander City, AL.

This year EndoChoice will be highlighting RescueNet™ in its booth at Digestive Disease Week (DDW®) in San Diego, California, and at the SGNA 43rd Annual Course in Seattle, Washington.

Commenting on the new product release, Mark Gilreath, Founder and CEO of EndoChoice said "This innovation is the result of our company's unique insights into the needs of GI caregivers to provide tools which improve the efficiency and effectiveness of their clinical procedures. RescueNet™ is the perfect addition to our family of Rescue® retrieval devices and the EndoChoice® portfolio of polypectomy devices, which includes the Boa® polypectomy snare, Mako™ biopsy forceps, Neptune® injection needle, and the TrapEase® polyp trap."

About DDW

Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW take place May 21-24, 2016, at the San Diego Convention Center, San Diego, CA. The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology.  More information can be found at

About SGNA 

The Society of Gastroenterology Nurses and Associates, Inc. (SGNA™) 43rd Annual Course in Seattle is the premier education and networking event dedicated to gastroenterology and endoscopy nursing professionals. The event will take place May 22-24, 2016 in Seattle, Washington. More information can be found at

About EndoChoice 

Based near Atlanta, Georgia, EndoChoice® (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy® (Fuse®) system. EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.

For more information, press only:

Company Contact:

Ryan Moskowitz
Senior Director, Marketing Communications

Investor Contacts:

Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020

Photo - 

SOURCE EndoChoice